{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:13:12Z","timestamp":1791677592623,"version":"4.3.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01HX001759"],"award-info":[{"award-number":["I01HX001759"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s40266-024-01110-3","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T18:01:58Z","timestamp":1712253718000},"page":"367-377","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinician and Family Caregiver Perspectives on Deprescribing Chronic Disease Medications in Older Nursing Home Residents Near the End of Life"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1236-0295","authenticated-orcid":false,"given":"Loren J.","family":"Schleiden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Klima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keri L.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Ersek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob E.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan P.","family":"Hickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Cashy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florentina E.","family":"Sileanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn T.","family":"Thorpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,4]]},"reference":[{"issue":"1","key":"1110_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jpainsymman.2013.02.021","volume":"47","author":"D Hui","year":"2014","unstructured":"Hui D, Nooruddin Z, Didwaniya N, et al. Concepts and definitions for \u201cactively dying\u201d, \u201cend of life\u201d, \u201cterminally ill\u201d, \u201cterminal care\u201d, and \u201ctransition of care\u201d: a systematic review. J Pain Symptom Manage. 2014;47(1):77\u201389. https:\/\/doi.org\/10.1016\/j.jpainsymman.2013.02.021.","journal-title":"J Pain Symptom Manage"},{"issue":"11","key":"1110_CR2","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1111\/jgs.13105","volume":"62","author":"J Tjia","year":"2014","unstructured":"Tjia J, Cutrona SL, Peterson D, Reed G, Andrade SE, Mitchell SL. Statin discontinuation in nursing home residents with advanced dementia. J Am Geriatr Soc. 2014;62(11):2095\u2013101. https:\/\/doi.org\/10.1111\/jgs.13105.","journal-title":"J Am Geriatr Soc"},{"key":"1110_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.16336","author":"DS Mack","year":"2020","unstructured":"Mack DS, Tjia J, Hume AL, Lapane KL. Prevalent statin use in long-stay nursing home residents with life-limiting illness. J Am Geriatr Soc. 2020. https:\/\/doi.org\/10.1111\/jgs.16336.","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"1110_CR4","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1111\/jgs.16727","volume":"68","author":"CT Thorpe","year":"2020","unstructured":"Thorpe CT, Sileanu FE, Mor MK, et al. Discontinuation of statins in veterans admitted to nursing homes near the end of life. J Am Geriatr Soc. 2020;68(11):2609\u201319. https:\/\/doi.org\/10.1111\/jgs.16727.","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"1110_CR5","doi-asserted-by":"publisher","first-page":"535 e1\u2013e12","DOI":"10.1016\/j.jamda.2015.03.003","volume":"16","author":"N Jokanovic","year":"2015","unstructured":"Jokanovic N, Tan EC, Dooley MJ, Kirkpatrick CM, Bell JS. Prevalence and factors associated with polypharmacy in long-term care facilities: a systematic review. J Am Med Dir Assoc. 2015;16(6):535 e1-e12. https:\/\/doi.org\/10.1016\/j.jamda.2015.03.003.","journal-title":"J Am Med Dir Assoc"},{"issue":"8","key":"1110_CR6","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.amjmed.2017.02.028","volume":"130","author":"L Morin","year":"2017","unstructured":"Morin L, Vetrano DL, Rizzuto D, Calderon-Larranaga A, Fastbom J, Johnell K. Choosing Wisely? Measuring the burden of medications in older adults near the end of life: nationwide, longitudinal cohort study. Am J Med. 2017;130(8):927-936 e9. https:\/\/doi.org\/10.1016\/j.amjmed.2017.02.028.","journal-title":"Am J Med"},{"issue":"6","key":"1110_CR7","doi-asserted-by":"publisher","first-page":"551 e1","DOI":"10.1016\/j.jamda.2017.02.021","volume":"18","author":"L Morin","year":"2017","unstructured":"Morin L, Vetrano DL, Grande G, Fratiglioni L, Fastbom J, Johnell K. Use of medications of questionable benefit during the last year of life of older adults with dementia. J Am Med Dir Assoc. 2017;18(6):551 e1-551 e7. https:\/\/doi.org\/10.1016\/j.jamda.2017.02.021.","journal-title":"J Am Med Dir Assoc"},{"issue":"9","key":"1110_CR8","doi-asserted-by":"publisher","first-page":"862 e1-9","DOI":"10.1016\/j.jamda.2016.06.011","volume":"17","author":"L Morin","year":"2016","unstructured":"Morin L, Laroche ML, Texier G, Johnell K. Prevalence of potentially inappropriate medication use in older adults living in nursing homes: a systematic review. J Am Med Dir Assoc. 2016;17(9):862 e1-9. https:\/\/doi.org\/10.1016\/j.jamda.2016.06.011.","journal-title":"J Am Med Dir Assoc"},{"key":"1110_CR9","doi-asserted-by":"publisher","unstructured":"By the American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria(R) for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674\u201394. https:\/\/doi.org\/10.1111\/jgs.15767.","DOI":"10.1111\/jgs.15767"},{"issue":"2","key":"1110_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/afu145","volume":"44","author":"D O'Mahony","year":"2015","unstructured":"O\u2019Mahony D, O\u2019Sullivan D, Byrne S, O\u2019Connor MN, Ryan C, Gallagher P. STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213\u20138. https:\/\/doi.org\/10.1093\/ageing\/afu145.","journal-title":"Age Ageing"},{"issue":"10","key":"1110_CR11","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s00228-018-2507-4","volume":"74","author":"L Morin","year":"2018","unstructured":"Morin L, Laroche ML, Vetrano DL, Fastbom J, Johnell K. Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: a European expert consensus. Eur J Clin Pharmacol. 2018;74(10):1333\u201342. https:\/\/doi.org\/10.1007\/s00228-018-2507-4.","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"1110_CR12","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","volume":"175","author":"IA Scott","year":"2015","unstructured":"Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827\u201334. https:\/\/doi.org\/10.1001\/jamainternmed.2015.0324.","journal-title":"JAMA Intern Med"},{"issue":"2","key":"1110_CR13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1001\/jamainternmed.2013.12963","volume":"174","author":"CL Tseng","year":"2014","unstructured":"Tseng CL, Soroka O, Maney M, Aron DC, Pogach LM. Assessing potential glycemic overtreatment in persons at hypoglycemic risk. JAMA Intern Med. 2014;174(2):259\u201368. https:\/\/doi.org\/10.1001\/jamainternmed.2013.12963.","journal-title":"JAMA Intern Med"},{"key":"1110_CR14","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. 6. Glycemic targets: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S83\u201396. https:\/\/doi.org\/10.2337\/dc22-S006.","DOI":"10.2337\/dc22-S006"},{"issue":"9","key":"1110_CR15","doi-asserted-by":"publisher","first-page":"655","DOI":"10.7326\/M17-1362","volume":"167","author":"PR Conlin","year":"2017","unstructured":"Conlin PR, Colburn J, Aron D, Pries RM, Tschanz MP, Pogach L. Synopsis of the 2017 U.S. Department of Veterans Affairs\/U.S. Department of Defense Clinical Practice Guideline: management of type 2 diabetes mellitus. Ann Intern Med. 2017;167(9):655\u201363. https:\/\/doi.org\/10.7326\/M17-1362.","journal-title":"Ann Intern Med"},{"issue":"2","key":"1110_CR16","doi-asserted-by":"publisher","first-page":"308","DOI":"10.2337\/dc15-2512","volume":"39","author":"MN Munshi","year":"2016","unstructured":"Munshi MN, Florez H, Huang ES, et al. Management of diabetes in long-term care and skilled nursing facilities: a position statement of the American Diabetes Association. Diabetes Care. 2016;39(2):308\u201318. https:\/\/doi.org\/10.2337\/dc15-2512.","journal-title":"Diabetes Care"},{"issue":"4","key":"1110_CR17","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/jgs.16360","volume":"68","author":"JD Niznik","year":"2020","unstructured":"Niznik JD, Hunnicutt JN, Zhao X, et al. Deintensification of diabetes medications among veterans at the end of life in VA nursing homes. J Am Geriatr Soc. 2020;68(4):736\u201345. https:\/\/doi.org\/10.1111\/jgs.16360.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"1110_CR18","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1001\/jamainternmed.2014.7345","volume":"175","author":"KJ Lipska","year":"2015","unstructured":"Lipska KJ, Ross JS, Miao Y, Shah ND, Lee SJ, Steinman MA. Potential overtreatment of diabetes mellitus in older adults with tight glycemic control. JAMA Intern Med. 2015;175(3):356\u201362. https:\/\/doi.org\/10.1001\/jamainternmed.2014.7345.","journal-title":"JAMA Intern Med"},{"issue":"4","key":"1110_CR19","doi-asserted-by":"publisher","first-page":"588","DOI":"10.2337\/dc14-0599","volume":"38","author":"CT Thorpe","year":"2015","unstructured":"Thorpe CT, Gellad WF, Good CB, Zhang S, Zhao X, Mor M, Fine MJ. Tight glycemic control and use of hypoglycemic medications in older veterans with type 2 diabetes and comorbid dementia. Diabetes Care. 2015;38(4):588\u201395. https:\/\/doi.org\/10.2337\/dc14-0599.","journal-title":"Diabetes Care"},{"key":"1110_CR20","doi-asserted-by":"publisher","unstructured":"Moreno G, Mangione CM, Kimbro L, Vaisberg E. Guidelines abstracted from the American Geriatrics Society Guidelines for improving the care of older adults with diabetes mellitus: 2013 update. Practice Guideline Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't. J Am Geriatr Soc. 2013;61(11):2020\u20136. https:\/\/doi.org\/10.1111\/jgs.12514.","DOI":"10.1111\/jgs.12514"},{"issue":"1","key":"1110_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11906-019-1012-1","volume":"22","author":"M Vu","year":"2020","unstructured":"Vu M, Schleiden LJ, Harlan ML, Thorpe CT. Hypertension management in nursing homes: review of evidence and considerations for care. Curr Hypertens Rep. 2020;22(1):8. https:\/\/doi.org\/10.1007\/s11906-019-1012-1.","journal-title":"Curr Hypertens Rep."},{"issue":"1","key":"1110_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jamda.2020.05.060","volume":"22","author":"M Vu","year":"2021","unstructured":"Vu M, Sileanu FE, Aspinall SL, et al. Antihypertensive deprescribing in older adult veterans at end of life admitted to veteran affairs nursing homes. J Am Med Dir Assoc. 2021;22(1):132-140 e5. https:\/\/doi.org\/10.1016\/j.jamda.2020.05.060.","journal-title":"J Am Med Dir Assoc"},{"issue":"12","key":"1110_CR23","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1001\/jamainternmed.2015.5110","volume":"175","author":"JB Sussman","year":"2015","unstructured":"Sussman JB, Kerr EA, Saini SD, et al. Rates of deintensification of blood pressure and glycemic medication treatment based on levels of control and life expectancy in older patients with diabetes mellitus. JAMA Intern Med. 2015;175(12):1942\u20139. https:\/\/doi.org\/10.1001\/jamainternmed.2015.5110.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"1110_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12933-018-0673-4","volume":"17","author":"FA McAlister","year":"2018","unstructured":"McAlister FA, Lethebe BC, Lambe C, Williamson T, Lowerison M. Control of glycemia and blood pressure in British adults with diabetes mellitus and subsequent therapy choices: a comparison across health states. Cardiovasc Diabetol. 2018;17(1):27. https:\/\/doi.org\/10.1186\/s12933-018-0673-4.","journal-title":"Cardiovasc Diabetol."},{"issue":"6","key":"1110_CR25","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1111\/1475-6773.13074","volume":"53","author":"W Song","year":"2018","unstructured":"Song W, Intrator O, Lee S, Boockvar K. Antihypertensive drug deintensification and recurrent falls in long-term care. Health Serv Res. 2018;53(6):4066\u201386. https:\/\/doi.org\/10.1111\/1475-6773.13074.","journal-title":"Health Serv Res"},{"key":"1110_CR26","unstructured":"AMDA. Ten Things Physicians and Patients Should Question. 2013. Choosing Wisely. http:\/\/www.choosingwisely.org\/wp-content\/uploads\/2015\/02\/AMDA-Choosing-Wisely-List.pdf."},{"key":"1110_CR27","doi-asserted-by":"publisher","unstructured":"Holmes HM, Sachs GA, Shega JW, Hougham GW, Cox Hayley D, Dale W. Integrating palliative medicine into the care of persons with advanced dementia: identifying appropriate medication use. Clinical Trial Multicenter Study Research Support, Non-U.S. Gov't. J Am Geriatr Soc. 2008;56(7):1306\u201311. https:\/\/doi.org\/10.1111\/j.1532-5415.2008.01741.x.","DOI":"10.1111\/j.1532-5415.2008.01741.x"},{"issue":"1","key":"1110_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40266-013-0134-4","volume":"31","author":"G Onder","year":"2014","unstructured":"Onder G, Landi F, Fusco D, et al. Recommendations to prescribe in complex older adults: results of the CRIteria to assess appropriate Medication use among Elderly complex patients (CRIME) project. Drugs Aging. 2014;31(1):33\u201345. https:\/\/doi.org\/10.1007\/s40266-013-0134-4.","journal-title":"Drugs Aging"},{"issue":"4","key":"1110_CR29","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/ageing\/afx005","volume":"46","author":"AH Lavan","year":"2017","unstructured":"Lavan AH, Gallagher P, Parsons C, O\u2019Mahony D. STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation. Age Ageing. 2017;46(4):600\u20137. https:\/\/doi.org\/10.1093\/ageing\/afx005.","journal-title":"Age Ageing"},{"issue":"5","key":"1110_CR30","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1001\/jamainternmed.2015.0289","volume":"175","author":"JS Kutner","year":"2015","unstructured":"Kutner JS, Blatchford PJ, Taylor DH Jr, et al. Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. JAMA Intern Med. 2015;175(5):691\u2013700. https:\/\/doi.org\/10.1001\/jamainternmed.2015.0289.","journal-title":"JAMA Intern Med"},{"key":"1110_CR31","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-2116","author":"JD Niznik","year":"2022","unstructured":"Niznik JD, Zhao X, Slieanu F, et al. Effect of deintensifying diabetes medications on negative events in older veteran nursing home residents. Diabetes Care. 2022. https:\/\/doi.org\/10.2337\/dc21-2116.","journal-title":"Diabetes Care"},{"key":"1110_CR32","unstructured":"Hickson RP, Sileanu FE, Zhao X, et al. Outcomes of antihypertensive deintensification in veteran community living center residents with limited life expectancy and\/or advanced dementia. In: Presented at: Veterans Affairs (VA) HSR&D\/QUERI National Meeting; February 8, 2023, Baltimore."},{"issue":"8","key":"1110_CR33","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1111\/jgs.18362","volume":"71","author":"C Thomas","year":"2023","unstructured":"Thomas C, Ellison H, Taffet GE. Deprescribing statins, considerations for informed decision making. J Am Geriatr Soc. 2023;71(8):2685\u20139. https:\/\/doi.org\/10.1111\/jgs.18362.","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"1110_CR34","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1111\/jgs.16777","volume":"68","author":"DS Mack","year":"2020","unstructured":"Mack DS, Baek J, Tjia J, Lapane KL. Statin discontinuation and life-limiting illness in non-skilled stay nursing homes at admission. J Am Geriatr Soc. 2020;68(12):2787\u201396. https:\/\/doi.org\/10.1111\/jgs.16777.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"1110_CR35","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/jgs.16346","volume":"68","author":"SP Springer","year":"2020","unstructured":"Springer SP, Mor MK, Sileanu F, et al. Incidence and predictors of aspirin discontinuation in older adult veteran nursing home residents at end of life. J Am Geriatr Soc. 2020;68(4):725\u201335. https:\/\/doi.org\/10.1111\/jgs.16346.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"1110_CR36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","volume":"36","author":"A Elixhauser","year":"1998","unstructured":"Elixhauser A, Steiner C, Harris DR, Coffey RN. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8\u201327.","journal-title":"Med Care"},{"issue":"4","key":"1110_CR37","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s11135-017-0574-8","volume":"52","author":"B Saunders","year":"2018","unstructured":"Saunders B, Sim J, Kingstone T, Baker S, Waterfield J, Bartlam B, Burroughs H, Jinks C. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2018;52(4):1893\u2013907. https:\/\/doi.org\/10.1007\/s11135-017-0574-8.","journal-title":"Qual Quant"},{"key":"1110_CR38","volume-title":"Doing qualitative research","author":"B Crabtree","year":"1999","unstructured":"Crabtree B, Miller W. Doing qualitative research. 2nd ed. London: Sage Publications; 1999.","edition":"2"},{"issue":"3","key":"1110_CR39","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/geront\/gnz116","volume":"60","author":"C Lundby","year":"2019","unstructured":"Lundby C, Graab\u00e6k T, Ryg J, S\u00f8ndergaard J, Potteg\u00e5rd A, Nielsen DS. \u201c\u2026 Above all, it\u2019s a matter of this person\u2019s quality of life\u201d: health care professionals\u2019 perspectives on deprescribing in older patients with limited life expectancy. Gerontologist. 2019;60(3):439\u201349. https:\/\/doi.org\/10.1093\/geront\/gnz116.","journal-title":"Gerontologist"},{"issue":"6","key":"1110_CR40","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1111\/jgs.15804","volume":"67","author":"E Reeve","year":"2019","unstructured":"Reeve E, Low LF, Hilmer SN. Attitudes of older adults and caregivers in australia toward deprescribing. J Am Geriatr Soc. 2019;67(6):1204\u201310. https:\/\/doi.org\/10.1111\/jgs.15804.","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"1110_CR41","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1111\/j.1532-5415.2008.01916.x","volume":"56","author":"KT Bain","year":"2008","unstructured":"Bain KT, Holmes HM, Beers MH, Maio V, Handler SM, Pauker SG. Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process. J Am Geriatr Soc. 2008;56(10):1946\u201352. https:\/\/doi.org\/10.1111\/j.1532-5415.2008.01916.x.","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"1110_CR42","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1001\/archinte.166.6.605","volume":"166","author":"HM Holmes","year":"2006","unstructured":"Holmes HM, Hayley DC, Alexander GC, Sachs GA. Reconsidering medication appropriateness for patients late in life. Arch Intern Med. 2006;166(6):605\u20139. https:\/\/doi.org\/10.1001\/archinte.166.6.605.","journal-title":"Arch Intern Med"},{"key":"1110_CR43","doi-asserted-by":"publisher","unstructured":"American Diabetes Association. 6. Glycemic targets: standards of medical care in diabetes\u20142018. Diabetes Care. 2018;41(Suppl 1):S55\u201364. https:\/\/doi.org\/10.2337\/dc18-S006.","DOI":"10.2337\/dc18-S006"},{"issue":"5","key":"1110_CR44","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1210\/jc.2019-00198","volume":"104","author":"D LeRoith","year":"2019","unstructured":"LeRoith D, Biessels GJ, Braithwaite SS, et al. Treatment of diabetes in older adults: an endocrine society* clinical practice guideline. J Clin Endocrinol Metab. 2019;104(5):1520\u201374. https:\/\/doi.org\/10.1210\/jc.2019-00198.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1110_CR45","doi-asserted-by":"publisher","DOI":"10.2196\/15385","volume":"21","author":"L Monteiro","year":"2019","unstructured":"Monteiro L, Mricoto T, Solha I, Ribeiro-Vaz I, Martins C, Monteiro-Soares M. Reducing potentially inappropriate prescriptions for older patients using computerized decision support tools: systematic review. J Med Internet Res. 2019;21(11): e15385. https:\/\/doi.org\/10.2196\/15385.","journal-title":"J Med Internet Res"},{"issue":"5","key":"1110_CR46","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/bcp.13861","volume":"85","author":"C Lundby","year":"2019","unstructured":"Lundby C, Graabaek T, Ryg J, S\u00f8ndergaard J, Potteg\u00e5rd A, Nielsen DS. Health care professionals\u2019 attitudes towards deprescribing in older patients with limited life expectancy: a systematic review. Br J Clin Pharmacol. 2019;85(5):868\u201392. https:\/\/doi.org\/10.1111\/bcp.13861.","journal-title":"Br J Clin Pharmacol"},{"key":"1110_CR47","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.3389\/fphar.2020.01268","volume":"11","author":"S Crutzen","year":"2020","unstructured":"Crutzen S, Baas G, Abou J, et al. Barriers and enablers of older patients to deprescribing of cardiometabolic medication: a focus group study. Front Pharmacol. 2020;11:1268. https:\/\/doi.org\/10.3389\/fphar.2020.01268.","journal-title":"Front Pharmacol"},{"issue":"4","key":"1110_CR48","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/jgs.16370","volume":"68","author":"AN Pickering","year":"2020","unstructured":"Pickering AN, Hamm ME, Dawdani A, Hanlon JT, Thorpe CT, Gellad WF, Radomski TR. Older patient and caregiver perspectives on medication value and deprescribing: a qualitative study. J Am Geriatr Soc. 2020;68(4):746\u201353. https:\/\/doi.org\/10.1111\/jgs.16370.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"1110_CR49","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-054279","volume":"12","author":"G Peat","year":"2022","unstructured":"Peat G, Fylan B, Marques I, Raynor DK, Breen L, Olaniyan J, Alldred DP. Barriers and facilitators of successful deprescribing as described by older patients living with frailty, their informal carers and clinicians: a qualitative interview study. BMJ Open. 2022;12(3): e054279. https:\/\/doi.org\/10.1136\/bmjopen-2021-054279.","journal-title":"BMJ Open"},{"key":"1110_CR50","doi-asserted-by":"publisher","unstructured":"DiScala S, Talebreza S, Lowery AW, Bowman EH, Palunas N, Ngodup T. When you know less is more but need the patient and family to buy in: using SPIKES for deprescribing (TH338). J Pain Symptom Manag. 2020;59(2):426-427. https:\/\/doi.org\/10.1016\/j.jpainsymman.2019.12.076.","DOI":"10.1016\/j.jpainsymman.2019.12.076"},{"key":"1110_CR51","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13886","author":"B Chan","year":"2023","unstructured":"Chan B, Isenor JE, Kennie-Kaulbach N. Categorization of deprescribing communication tools: a scoping review. Basic Clin Pharmacol Toxicol. 2023. https:\/\/doi.org\/10.1111\/bcpt.13886.","journal-title":"Basic Clin Pharmacol Toxicol."},{"issue":"12","key":"1110_CR52","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1111\/jgs.14519","volume":"64","author":"EC Geijteman","year":"2016","unstructured":"Geijteman EC, Dees MK, Tempelman MMA, Huisman BAA, Arevalo JJ, Perez RSGM, Zuylen LV, Heide AH. Understanding the continuation of potentially inappropriate medications at the end of life: perspectives from individuals and their relatives and physicians. J Am Geriatr Soc. 2016;64(12):2602\u20134. https:\/\/doi.org\/10.1111\/jgs.14519.","journal-title":"J Am Geriatr Soc."},{"issue":"3","key":"1110_CR53","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.pec.2021.06.021","volume":"105","author":"NJ Ailabouni","year":"2022","unstructured":"Ailabouni NJ, Rebecca Weir K, Reeve E, Turner JT, Wilson Norton J, Gray SL. Barriers and enablers of older adults initiating a deprescribing conversation. Patient Educ Couns. 2022;105(3):615\u201324. https:\/\/doi.org\/10.1016\/j.pec.2021.06.021.","journal-title":"Patient Educ Couns"},{"key":"1110_CR54","doi-asserted-by":"publisher","first-page":"204209862211181","DOI":"10.1177\/20420986221118143","volume":"13","author":"MT Antonelli","year":"2022","unstructured":"Antonelli MT, Cox JS, Saphirak C, Gurwitz JH, Singh S, Mazor KM. Motivating deprescribing conversations for patients with Alzheimer\u2019s disease and related dementias: a descriptive study. Ther Adv Drug Saf. 2022;13:20420986221118144. https:\/\/doi.org\/10.1177\/20420986221118143.","journal-title":"Ther Adv Drug Saf."},{"issue":"3","key":"1110_CR55","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40266-021-00918-7","volume":"39","author":"J Abou","year":"2022","unstructured":"Abou J, Crutzen S, Tromp V, et al. Barriers and enablers of healthcare providers to deprescribe cardiometabolic medication in older patients: a focus group study. Drugs Aging. 2022;39(3):209\u201321. https:\/\/doi.org\/10.1007\/s40266-021-00918-7.","journal-title":"Drugs Aging"},{"issue":"1","key":"1110_CR56","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/ejhpharm-2016-000967","volume":"24","author":"P Duncan","year":"2017","unstructured":"Duncan P, Duerden M, Payne RA. Deprescribing: a primary care perspective. Eur J Hosp Pharm. 2017;24(1):37\u201342. https:\/\/doi.org\/10.1136\/ejhpharm-2016-000967.","journal-title":"Eur J Hosp Pharm"},{"issue":"4","key":"1110_CR57","doi-asserted-by":"publisher","first-page":"311","DOI":"10.7861\/clinmedicine.19-4-311","volume":"19","author":"J Thompson","year":"2019","unstructured":"Thompson J. Deprescribing in palliative care. Clin Med (Lond). 2019;19(4):311\u20134. https:\/\/doi.org\/10.7861\/clinmedicine.19-4-311.","journal-title":"Clin Med (Lond)"},{"issue":"1","key":"1110_CR58","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/jgs.18047","volume":"71","author":"S Lee","year":"2023","unstructured":"Lee S, Bobb Swanson M, Fillman A, Carnahan RM, Seaman AT, Reisinger HS. Challenges and opportunities in creating a deprescribing program in the emergency department: a qualitative study. J Am Geriatr Soc. 2023;71(1):62\u201376. https:\/\/doi.org\/10.1111\/jgs.18047.","journal-title":"J Am Geriatr Soc"},{"key":"1110_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20043543","author":"K Ie","year":"2023","unstructured":"Ie K, Machino R, Albert SM, et al. Deprescribing as an opportunity to facilitate patient-centered care: a qualitative study of general practitioners and pharmacists in Japan. Int J Environ Res Public Health. 2023. https:\/\/doi.org\/10.3390\/ijerph20043543.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"1110_CR60","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12912-023-01179-y","volume":"22","author":"MO Little","year":"2023","unstructured":"Little MO, Hecker EJ, Colon-Emeric CS, Herndon L, McConnell ES, Xue TM, Berry SD. Perspectives on deprescribing in long-term care: qualitative findings from nurses, aides, residents, and proxies. BMC Nurs. 2023;22(1):27. https:\/\/doi.org\/10.1186\/s12912-023-01179-y.","journal-title":"BMC Nurs."},{"issue":"4","key":"1110_CR61","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/njh.0000000000000574","volume":"21","author":"J Tjia","year":"2019","unstructured":"Tjia J, DeSanto-Madeya S, Mazor KM, et al. Nurses\u2019 perspectives on family caregiver medication management support and deprescribing. J Hosp Palliat Nurs. 2019;21(4):312\u20138. https:\/\/doi.org\/10.1097\/njh.0000000000000574.","journal-title":"J Hosp Palliat Nurs"},{"issue":"1","key":"1110_CR62","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1016\/j.sapharm.2020.05.025","volume":"17","author":"A Elbeddini","year":"2021","unstructured":"Elbeddini A, Prabaharan T, Almasalkhi S, Tran C, Zhou Y. Barriers to conducting deprescribing in the elderly population amid the COVID-19 pandemic. Res Social Adm Pharm. 2021;17(1):1942\u20135. https:\/\/doi.org\/10.1016\/j.sapharm.2020.05.025.","journal-title":"Res Social Adm Pharm"}],"container-title":["Drugs &amp; Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-024-01110-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-024-01110-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-024-01110-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T11:39:47Z","timestamp":1713267587000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-024-01110-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1110"],"URL":"https:\/\/doi.org\/10.1007\/s40266-024-01110-3","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"7 March 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was funded by a grant from the US Department of Veterans Affairs (I01HX001759, IIR 14-306; PI Carolyn T. Thorpe). Ryan Hickson was supported as a Postdoctoral Fellow in Advanced Geriatrics with the Geriatric Research, Education, and Clinical Center at the Veterans Affairs Healthcare System, Pittsburgh, PA. At the time of submission, Ryan Hickson was employed by the US Food and Drug Administration (FDA). The contents do not represent the views of the US Department of Veterans Affairs, the FDA<u>,<\/u> or the United States Government. The views expressed are those of the authors, and no official endorsement by the Department of Veterans Affairs (VA) or the United States government is intended or should be inferred.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"No authors have relevant conflicts of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This project was approved by the institutional review boards (IRBs) at the VA Pittsburgh Healthcare System (IRB #Pro00001563; date approved: 03\/16\/2016) and Corporal Michael J. Crescenz VA Medical Center (IRB #01627, Prom #0005: date approved: 07\/05\/2016). Study interviews were conducted from 12\/04\/2020 through 08\/19\/2021. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"To protect interview participant privacy, transcript data cannot be openly shared.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"All authors made substantial contributions to the conception or design of the work (LS, GK, ME, KR, DS, JC, FS, CT) and\/or acquisition (LS, GK, KR, ME, DS, JC, FS, CT), analysis (LS, GK, KR, JR, CT), or interpretation (LS, GK, KR, ME, JR, RH, CT) of data for the work. All authors have read and approved the final version of the manuscript and agree to be accountable for all aspects of the work.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}